Real-time enrollment status for this copd clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06283966 |
| Recruiting Status | Recruiting |
| Condition | COPD |
| Phase | Clinical Trial |
| Target Enrollment | 5,000 participants |
| Active Locations | 233 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of March 2, 2026: Clinical trial NCT06283966 is currently recruiting participants. This clinical trial study for copd is actively seeking new participants at 233 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06283966 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 233 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06283966 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.